On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Is Sublingual Immunotherapy an Effective Treatment Option for Allergic Rhinitis?
Sublingual immunotherapy was developed nearly 30 years ago as an alternative to subcutaneous immunotherapy, an alternative that might trigger fewer systematic reactions such as anaphylaxis.
Recurrent Thymoma: Surgical Resection Leads to Good Outcomes
December 5th 2014Thymoma is rare and most known for its presence in 15% of patients who have myasthenia gravis. Thymoma tumors can be quite large. Surgery is the mainstay of treatment for thymoma, but when thymoma recurs (as it does in 10% to 30% of patients), the best course of action is often unclear.
Which Stents Are Better: Drug-Eluting or Bare Metal?
December 5th 2014Cardiologists have discussed the pros and cons of drug-eluting stents (DES) for several years. Some evidence seems to indicate that DES reduce risk of restenosis or ischemia-driven target vessel revascularization. They may, however, be more prone than bare metal stents to late (beyond 1 year) and sudden coronary artery occlusion.
CDC: Ebola Fears May Have Caused US Deaths
US health care workers' concern over protecting themselves from Ebola infection may have compromised the care of some patients who turned out not to have Ebola, but whose care was delayed until Ebola test results were done. According to the US Centers for Disease Control and Prevention's Dec. 5 Morbidity and Mortality Weekly Report, at least 2 patients who tested negative for Ebola died from other causes.
Women with Rheumatoid Arthritis at Greater Risk of Dying from Respiratory Disease
Women with rheumatoid arthritis are at greater risk for respiratory-related death than women without the disease, according to data presented at the 2014 American College of Rheumatology Annual Meeting.
MRIs May Be Able to Detect Patients at Risk for Developing Multiple Sclerosis
Results from a study published in the International Journal of MS Care suggest that magnetic resonance imaging may be used to identify asymptomatic patients who are at higher risk for developing multiple sclerosis.
AbbVie Gets Closer to EU Approval of New Hepatitis C Drug
December 5th 2014A committee for the European Medicines Agency has recommended approval for a hepatitis C drug combination, a key step to winning European marketing authorization for the drug maker AbbVie. The recommendation for marketing authorization is for AbbVie's investigational drug named Exviera (dasabuvir) and Viekirax (ombitasvir, paritaprevir and ritonavir) for the treatment of chronic hepatitis C virus infection in combination with other medicine.
Promising Drug for Spinal Cord Injury
A study with rats appears to show promise for a drug that could help axons crushed in spinal cord injuries regenerate. Reporting in Nature Bradley Lang PhD, lead author of the study and a graduate student in the Lab of Jerry Silver, PhD, a professor of neurosciences at Case Western Reserve University School Medicine, say they found a way to design a drug that would help axons grow without having to touch the healing spinal cord.
FDA Letter Stalls Bristol-Myers Squibb's Hepatitis C Drug Application
December 5th 2014The US Food and Drug Administration recently rejected a bid by Bristol-Myers Squibb to win regulatory approval for its hepatitis C drug daclatasvir, pending further information requested in a Complete Response Letter issued by the agency.
Rogue Proteins Found in MS Brains
Could multiple sclerosis be caused by a "rogue protein" that attacks the central nervous system? That's the hypothesis of a research team from the University of Surrey, Guildford, UK and researchers at the University of Texas Houston Medical School's Mitchell Center for Alzheimer's Disease and Related Brain Disorders.
Chikungunya (CHIKV) virus infection can be hard to distinguish from dengue. Both of these mosquito-borne, acute febrile illnesses have become endemic in the Caribbean and the Americas, with locally acquired cases also starting to turn up in Florida. A new proactive household CHIKV surveillance program begun in January 2014 in Puerto Rico found that cross-testing for dengue and CHIKV found that the actual incidence of CHIKV is higher than thought. By visiting households in addition to getting reports from public health agencies, the CDC found 282 cases per 100,000 residents.
FDA Approves Novel Treatment for Chronic Bone Marrow Disease
The US Food and Drug Administration (FDA) announced today the approval of a new use for Jakafi (ruxolitinib) to treat patients afflicted with polycythemia vera, a chronic type of bone marrow disease associated with phlebitis, splenomegaly, and other potentially severe symptoms.
Most Parents Would Remove their Child from a Daycare with Unvaccinated Kids
December 4th 2014University of Michigan (UM) C.S. Mott Children's Hospital National Poll on Children's Health found a large majority of parents – 74% – would remove their child from a daycare where other kids are unvaccinated.
Comorbidity Identified Between Bowel and Lung Diseases
December 4th 2014Individuals with airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) are more likely to be diagnosed with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, a new study published in the European Respiratory Journal suggested.
Nutritional Treatment Improves Hospital Outcomes in Older COPD Patients
December 3rd 2014Researchers report that nutrition treatment for patients with chronic obstructive pulmonary disease (COPD) aged 65 or older helps reduce of lengths of stay, hospital costs, and probability of returning to the hospital within 30 days.
Study Shows Positive Outcomes with Ixekizumab for the Treatment of Plaque Psoriasis
December 3rd 2014Researchers report that patients diagnosed with moderate to severe plaque psoriasis who were treated with ixekizumab, an investigational anti-interleukin-17A monoclonal antibody, have maintained a favorable clinical response over a year-long course of treatment.
Amiodarone: Dysrhythmic Drug with Thyroid Effects
December 3rd 2014Clinicians are most likely to prescribe amiodarone when they see patients who have recurrent ventricular dysrhythmias; paroxysmal supraventricular dysrhythmias including atrial fibrillation and flutter; and or need sinus rhythm maintenance after electrical cardioversion for atrial fibrillation.
Zigzag Calorie Cycling: A Novel Path to Weight Loss
December 3rd 2014Also known as alternate day fasting, "zigzag" caloric cycling calls for the dieter to eat the number of calories required to maintain weight one day, and then 25% of his or her energy needs on the fast day. Studies have shown that individuals who are compliant with this pattern can lose 4% to 8% of their body weight over 8 to 12 weeks.
Longer-wave Laser Effective in KP Symptom Treatment
According to a recent study published in JAMA Dermatology, a longer wavelength laser is an effective treatment option for keratosis pilaris (KP), a skin condition in which skin proteins form hard plugs within hair follicles, for improving skin roughness and textural irregularities.
CDC Approves New Ebola Treatment Centers
While there are currently no active cases of Ebola virus infection in the United States, the US Centers for Disease Control and Prevention has announced that 35 hospitals across the country are now designated treatment centers for the virus.
Gastroenterologists Consider Novel Procedure of POEM
Although the introduction of peroral endoscopic myotomy (POEM) for the treatment of achalasia, a condition that affects the ability of the esophagus to move food into the stomach, has caused quite a stir, clinicians are reminded to consider additional factors when discussing therapeutic options.
Researchers Report Positive Results for Brodalumab for Patients with Plaque Psoriasis
Amgen and AstraZeneca recently announced AMAGINE-2TM, a pivotal, multi-arm Phase 3 clinical trial, met all primary endpoints for brodalumab, an experimental drug designed for moderate to severe plaque psoriasis treatment.